Hyundai Bioscience To Request US FDA a Fast Track Processing For Its Monkeypox Treatment Drug
Hyundai Bioscience is going straight to the United States FDA along with the company’s broad-spectrum antiviral drug candidate for the purpose of treating the monkeypox disease. The company has decided for submitting a request for a fast track processing to the Food and Drug Administration (FDA) of the United States for the CP-COV03, which an […]
Continue Reading